Home / 2015 / January (page 6)

Monthly Archives: January 2015

New Insulin Glargine 300 Effective in Type 1 Diabetes

Glargine 300 more effective than glargine 100 currently available… Two single-dose studies were conducted in Japan and Europe to compare the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of new insulin glargine 300 U/ml (Gla-300) and insulin glargine 100 U/ml (Gla-100) in people with type 1 diabetes mellitus. In two double-blind, randomized, crossover …

Read More »

Metformin Has Positive Effect on Glucose Kinetics When Combined with Exercise

But the effects are modest and type 2 patients on metformin can do moderate exercise without undue fear of hypoglycemia… Before, during, and after a 45-min bout of exercise at 60% VO2max, glucose kinetics were determined by isotope tracer technique in patients with type 2 diabetes mellitus with metformin treatment …

Read More »

Sulfonylureas, Insulin, and Metformin Cancer Risks for Patients with Type 2 Diabetes

Can metformin reduce the risk of cancer for those with type 2 diabetes?… In previous studies, metformin has been shown to decrease the risk of cancer in type 2 diabetes. A recent meta-analysis showed a 34% reduction in the incidence of any cancer and a 33% reduction in cancer mortality; …

Read More »

Reduction of Renal Function and Exercise Capacity in Type 1 Diabetic Adolescents

Insulin resistance with increasing LDL cholesterol were related to low peak volume of oxygen level… Diabetic nephropathy and cardiovascular disease are strongly related in adults with type 1 diabetes, yet little is known about this relationship in adolescents prior to the onset of detectable clinical disease. The researchers hypothesized that …

Read More »

High Calorie Consumption after GDM Leads to Increased Insulin Resistance in Hispanic Women

The women also experienced reduced beta cell function…. Researchers from the University of Southern California, Los Angeles, assessed associations between dietary intake and rates of change in insulin resistance and β-cell function in Hispanic women with prior gestational diabetes mellitus (GDM). Sixty-two nondiabetic Hispanic women with pregnancies complicated by GDM …

Read More »

Phentermine and Topirimate ER (Qsymia) Studied for Type 2 Diabetes Patients

Diabetic patients can lose weight with medication specific for weight loss... In two randomized, double-blind and placebo-controlled studies, the safety and efficacy of treatment with phentermine (PHEN) and topiramate ER (TPM ER) (Qsymia) plus lifestyle for weight loss and glycemic benefits were measured. The studies included obese/overweight adults with type 2 diabetes. …

Read More »